Results 11 to 20 of about 40,064 (263)
The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome [PDF]
Journal of Addiction Medicine, 2016 Gamma-hydroxybutyric acid (GHB) withdrawal is a complex syndrome which can be potentially life-threatening. Additionally, GHB-dependent patients frequently report co-occurring substance use of other psychoactive drugs. We assessed the add-on effect of co-use on GHB withdrawal symptoms.We conducted an open-label, pretest-posttest design study with 95 ...
Kamal, R.M. +3 more
core +7 more sources
BMC Emergency Medicine, 2021 Background Patients who experience harms from alcohol and other substance use often seek care in the emergency department (ED). ED visits related to alcohol withdrawal have increased across the world during the COVID-19 pandemic.
Justin Jek-Kahn Koh +3 more
doaj +2 more sources
Opioid withdrawal presenting as delirium and role of buprenorphine: A case series
Indian Journal of Psychological Medicine, 2017 Opioid withdrawal is very rarely characterized by delirium unlike alcohol or benzodiazepine withdrawal. PubMed search through October 2016 reveals only two case series on delirium as feature of withdrawal in opioid dependence syndrome.
Sourav Das +3 more
doaj +2 more sources
A Case Report of Severe Delirium after Amantadine Withdrawal
Case Reports in Neurology, 2017 Amantadine is frequently used in addition to dopaminergic substances like dopamine agonists or L-Dopa in advanced Parkinson disease (PD). However, adverse effects like hallucinations limit its use.
Franz Marxreiter +3 more
doaj +3 more sources
BMC Pediatrics, 2022 Background Neonatal Opioid Withdrawal Syndrome (NOWS) is a significant public health issue and while millions of neonates are affected each year, an optimal pharmacologic weaning protocol has yet to be demonstrated.
Mary Beth Sutter +4 more
doaj +2 more sources
Psychomotor Agitation Non-responsive to Treatment: A Case Report of Phenibut Withdrawal Syndrome [PDF]
Frontiers in Psychiatry, 2021 Background and Objectives: Phenibut (4-amino-3-phenyl-butyric acid), acting as a GABA-B receptor agonist, has a beneficial effect on anxiety. Although its medical use is not approved in western countries, it can be easily obtained worldwide via the ...
Cecilia Maria Esposito +5 more
doaj +2 more sources
Outpatient alcohol detoxification: Implementation efficacy and outcome effectiveness of a model project [PDF]
, 2004 Background: The aim of the study was to examine the practicability and implementation efficacy of an alcohol outpatient detoxification model and the concomitant `motivational' psychotherapeutic approach.
Soyka, Michael +3 more
core +1 more source
European Psychiatry, 2023 Introduction Cannabis (aka marijuana) is the most frequently consumed illicit substance worldwide, and a subset of frequent cannabis smokers (up to 30%) develop dependence.
R. Sharma +4 more
doaj +1 more source
The relationship between addiction and hikikomori tendencies: a case-control study
Frontiers in Psychiatry, 2023 AimThe present study examined the relationship between addiction and hikikomori (extreme social withdrawal) symptoms.MethodA group of clinically referred addiction patients (n = 31) and a group of age- and gender-matched non-clinical controls (n = 34 ...
Peter Muris +4 more
doaj +1 more source
Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant
Frontiers in Psychiatry, 2021 Kratom or Mitragyna speciosa (Korth.) is an evergreen tree of the coffee family native to South-East Asia and Australasia. It is used by locals recreationally to induce stimulant and sedative effects and medically to soothe pain and opiate withdrawal ...
Alessandro E. Vento +8 more
doaj +1 more source